Synergy Innovation Co. Ltd (048870) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Synergy Innovation Co. Ltd (048870) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.55 Billion ≈ $7.15 Million USD) by net assets (₩267.96 Billion ≈ $181.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Synergy Innovation Co. Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Synergy Innovation Co. Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Synergy Innovation Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Synergy Innovation Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Synergy Innovation Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aimei Health Technology Co., Ltd Ordinary Share
NASDAQ:AFJK
|
-0.005x |
|
MODISON LIMITED
NSE:MODISONLTD
|
0.021x |
|
Kino Polska TV SA
WAR:KPL
|
0.086x |
|
BCnC Co. Ltd.
KQ:146320
|
0.030x |
|
Ultralife Corporation
NASDAQ:ULBI
|
0.017x |
|
Calitech Co Ltd
TWO:6532
|
0.019x |
|
Aspen Group Ltd
TA:ASGR
|
0.003x |
|
MICROPORT CARDIO.MEDTECH.
F:72X
|
N/A |
Annual Cash Flow Conversion Efficiency for Synergy Innovation Co. Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Synergy Innovation Co. Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 048870 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩182.74 Billion ≈ $123.84 Million |
₩26.47 Billion ≈ $17.94 Million |
0.145x | -8.82% |
| 2023-12-31 | ₩222.59 Billion ≈ $150.84 Million |
₩35.37 Billion ≈ $23.97 Million |
0.159x | +220.61% |
| 2022-12-31 | ₩139.91 Billion ≈ $94.82 Million |
₩6.93 Billion ≈ $4.70 Million |
0.050x | -72.35% |
| 2021-12-31 | ₩113.94 Billion ≈ $77.21 Million |
₩20.42 Billion ≈ $13.84 Million |
0.179x | +39.13% |
| 2020-12-31 | ₩79.21 Billion ≈ $53.68 Million |
₩10.20 Billion ≈ $6.92 Million |
0.129x | +81.40% |
| 2019-12-31 | ₩75.05 Billion ≈ $50.86 Million |
₩5.33 Billion ≈ $3.61 Million |
0.071x | +35.75% |
| 2018-12-31 | ₩53.79 Billion ≈ $36.45 Million |
₩2.81 Billion ≈ $1.91 Million |
0.052x | +133.22% |
| 2017-12-31 | ₩30.91 Billion ≈ $20.95 Million |
₩-4.87 Billion ≈ $-3.30 Million |
-0.157x | -80.74% |
| 2016-12-31 | ₩13.47 Billion ≈ $9.13 Million |
₩-1.17 Billion ≈ $-795.29K |
-0.087x | -128.06% |
| 2015-12-31 | ₩-19.56 Billion ≈ $-13.26 Million |
₩-6.08 Billion ≈ $-4.12 Million |
0.311x | +674.09% |
| 2014-12-31 | ₩30.09 Billion ≈ $20.39 Million |
₩-1.63 Billion ≈ $-1.10 Million |
-0.054x | -167.47% |
| 2013-12-31 | ₩42.26 Billion ≈ $28.64 Million |
₩3.39 Billion ≈ $2.30 Million |
0.080x | +185.63% |
| 2012-12-31 | ₩75.56 Billion ≈ $51.21 Million |
₩2.12 Billion ≈ $1.44 Million |
0.028x | -30.14% |
| 2008-12-31 | ₩134.48 Billion ≈ $91.13 Million |
₩5.40 Billion ≈ $3.66 Million |
0.040x | -77.22% |
| 2007-12-31 | ₩133.58 Billion ≈ $90.53 Million |
₩23.56 Billion ≈ $15.97 Million |
0.176x | -- |
About Synergy Innovation Co. Ltd
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more